| scholarly article | Q13442814 |
| P356 | DOI | 10.5301/TJ.5000405 |
| P698 | PubMed publication ID | 26350200 |
| P2093 | author name string | Patrizia Racca | |
| Libero Ciuffreda | |||
| Rosella Spadi | |||
| Agostino Ponzetti | |||
| Caterina Mecca | |||
| Francesco Pinta | |||
| Laura Fanchini | |||
| Marcello Zanini | |||
| P433 | issue | Suppl. 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| irinotecan | Q412197 | ||
| aflibercept | Q4689286 | ||
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Tumori | Q15757838 |
| P1476 | title | Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district | |
| P478 | volume | 102 |
| Q90714435 | Deciphering novel chemotherapy and its impact on dentistry |
| Q55094789 | Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases. |
| Q52630017 | Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. |
| Q38948950 | Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors |
| Q38807483 | Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology |
| Q55332559 | Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature. |
| Q37525339 | Osteonecrosis of the jaw associated with ziv-aflibercept |
| Q64101769 | Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology |
| Q57800097 | Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review |
| Q92148335 | Risk profile for antiangiogenic agent-related osteonecrosis of the jaws |
| Q93346859 | [Progress on medication-related osteonecrosis of the jaw] |
Search more.